Thematic Issue: Immuno-Oncology and Immunotherapy

被引：2

作者：

Zamyatnin, A. A., Jr. ^{[1
,2
]}

机构：

[1] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow 119991, Russia

[2] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow 119992, Russia

来源：

BIOCHEMISTRY-MOSCOW | 2019年 / 84卷 / 07期

关键词：

immunotherapy; immuno-oncology; anticancer vaccines; tumor-associated macrophages; CANCER-IMMUNOTHERAPY; INHIBITORS; THERAPY;

D O I：

10.1134/S0006297919070010

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Currently, the use of immunotherapeutic approaches for creating new efficient therapeutic agents for cancer treatment is considered as one of the most promising areas in oncology. Despite significant advances in immuno-oncology during the recent years, some unresolved problems remain. The articles included in this thematic issue highlight the topical aspects of cancer immunotherapy by presenting different viewpoints of scientists, physicians, and drug developers.

引用

页码：693 / 694

页数：2

共 14 条

[1] Immunotherapeutic Approaches for the Treatment of Colorectal Cancer [J].

Abakushina, E. V. ;

Gelm, Yu. V. ;

Pasova, I. A. ;

Bazhin, A. V. .

BIOCHEMISTRY-MOSCOW, 2019, 84 (07) :720-728

[2] The clinical importance of understanding the evolution of papillomaviruses [J].

Bravo, Ignacio G. ;

de Sanjose, Silvia ;

Gottschling, Marc .

TRENDS IN MICROBIOLOGY, 2010, 18 (10) :432-438

[3] A Milestone Review on How Macrophages Affect Tumor Growth [J].

Caux, Christophe ;

Ramos, Rodrigo Nalio ;

Prendergast, George C. ;

Bendriss-Vermare, Nathalie ;

Menetrier-Caux, Christine .

CANCER RESEARCH, 2016, 76 (22) :6439-6442

[4] T-Cell Engagers Based Bioassay for Evaluation of PD-1/PD-L1 Inhibitors Activity [J].

Doronin, A. N. ;

Gordeev, A. A. ;

Kozlov, A. E. ;

Smirnova, Ya. A. ;

Puchkova, M. Yu. ;

Ekimova, V. M. ;

Basovskiy, Yu. I. ;

Solovyev, V. V. .

BIOCHEMISTRY-MOSCOW, 2019, 84 (07) :711-719

[5] The Role of Checkpoint Inhibitors and Cytokines in Adoptive Cell-Based Cancer Immunotherapy with Genetically Modified T Cells [J].

Gershovich, P. M. ;

Karabelskii, A. V. ;

Ulitin, A. B. ;

Ivanov, R. A. .

BIOCHEMISTRY-MOSCOW, 2019, 84 (07) :695-710

[6] Advances and Challenges of Nanoparticle-Based Macrophage Reprogramming for Cancer Immunotherapy [J].

Kapitanova, K. S. ;

Naumenko, V. A. ;

Garanina, A. S. ;

Melnikov, P. A. ;

Abakumov, M. A. ;

Alieva, I. B. .

BIOCHEMISTRY-MOSCOW, 2019, 84 (07) :729-745

[7] Chimeric antigen receptor T-cell therapy - assessment and management of toxicities [J].

Neelapu, Sattva S. ;

Tummala, Sudhakar ;

Kebriaei, Partow ;

Wierda, William ;

Gutierrez, Cristina ;

Locke, Frederick L. ;

Komanduri, Krishna V. ;

Lin, Yi ;

Jain, Nitin ;

Daver, Naval ;

Westin, Jason ;

Gulbis, Alison M. ;

Loghin, Monica E. ;

de Groot, John F. ;

Adkins, Sherry ;

Davis, Suzanne E. ;

Rezvani, Katayoun ;

Hwu, Patrick ;

Shpall, Elizabeth J. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2018, 15 (01) :47-62

[8] The blockade of immune checkpoints in cancer immunotherapy [J].

Pardoll, Drew M. .

NATURE REVIEWS CANCER, 2012, 12 (04) :252-264

[9] Cysteine Cathepsins: Potential Applications in Diagnostics and Therapy of Malignant Tumors [J].

Petushkova, A. I. ;

Savvateeva, L. V. ;

Korolev, D. O. ;

Zamyatnin, A. A., Jr. .

BIOCHEMISTRY-MOSCOW, 2019, 84 (07) :746-761

[10] Dendritic Cell-Based Cancer Vaccines [J].

Santos, Patricia M. ;

Butterfield, Lisa H. .

JOURNAL OF IMMUNOLOGY, 2018, 200 (02) :443-449

← 1 2 →